Navigation Links
Cardium Announces Investor Presentation and Corporate Update Webcast
Date:12/3/2008

SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) announces that the Company will be presenting a webcast providing an investor presentation, corporate update and review of its ongoing business strategies and plans. The webcast will be presented following the close of market today at 4:30 PM (Eastern Time) and can be accessed at http://www.investorcalendar.com/IC/CEPage.asp?ID=138418 at that time. The webcast will also be accessible for the following thirty days via the Investors section at "Calendar of Events" on the Company's website at http://www.cardiumthx.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

Forward-Looking Statements in Webcast

Except for statements of historical fact, the matters discussed in the webcast are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. Actual results may also differ substantially from those described in or contemplated by the webcast due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties inherent in the conduct of human clinical trials, including the timing, costs and results of such trials, our limited experience in the development, testing and marketing of therapeutic hypothermia devices, uncertainties regarding potential corporate development partners, our dependence upon proprietary technology, uncertainties regarding ongoing needs to support product development programs and other cash expenditures, our history of operating losses and accumulated deficits, risks and uncertainties related to our ability to raise cash under difficult capital market conditions, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2008 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit http://www.cardiumthx.com.

Cardium Therapeutics(TM) and Generx(TM) are trademarks of Cardium

                              Therapeutics, Inc.
Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM) and Excellarate(TM) are
                     trademarks of Tissue Repair Company.
       InnerCool Therapies(R), InnerCool(R), Celsius Control System(R),
  RapidBlue(TM), CoolBlue(TM), Accutrol(R), Temperature Control Element(R),
      TCE(R) and UroCool(TM) are trademarks of InnerCool Therapies, Inc.

'/>"/>
SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cardium Completes $6.0 Million Financing
2. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
3. Cardiums InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
4. Cardium Reports on Recent Highlights and Financial Results
5. An international first at the CHUM - Promising treatment in regeneration of the myocardium through the use of stem cells
6. AANMA Announces Launch of Free Web-Based Education Program for Patients Transitioning From CFC to HFA Inhalers
7. Lucas Group Announces Their Executive Recruitment Military Hiring Conference Schedule for December 2008
8. Axiom Consulting Partners Announces the Results of its Return On Sales Investment Survey
9. United American Healthcare Corporation Announces Stock Repurchase Program
10. eOn Communications Announces GSA Contract
11. Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
Breaking Medicine Technology: